Overview

Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Status:
Completed

Trial end date:
2003-12-01

Target enrollment:

Participant gender:

Summary

To investigate the effects of food and dose regimen on the antiviral effects of Maraviroc (UK-427,857) in patients with human immunodeficiency virus (HIV)

Phase:

Phase 2

Details

Lead Sponsor:

ViiV Healthcare

Collaborator:

Pfizer

Treatments:

Maraviroc